A Study Comparing SHR-3167 With Insulin Degludec in Adults With Type 2 Diabetes Currently Treated With Basal Insulin
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 680 participants.
Also called NCT07913061
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 680 participants
- Registry
-
NCT07913061
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07913061. Randomized; no masking; primary purpose treatment. Start 2026-11 (anticipated); primary completion 2028-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study Comparing SHR-3167 With Insulin Degludec in Adults With Type 2 Diabetes Currently Treated With Basal Insulin
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- SHR-3167
- Intervention (Drug)
- insulin degludec
- Lead sponsor
- Jiangsu HengRui Medicine Co., Ltd.
Record details
- Record id
cardio:ct-nct07913061- Content hash
55e45dd7be45b04ef05d1ab22bfcaa4d03c927a2d07fe92177d73b3d8c76dd64